期刊文献+

年轻女性与中老年女性乳腺癌钼靶表现对比研究

下载PDF
导出
摘要 与中老年女性相比,40岁以下年轻女性乳腺癌是少见的,但40岁以下年轻女性乳腺癌预后较差,经常表现出侵袭性更强的生物学行为,较晚的临床分期,较高的组织学分级,更多的肿瘤周围血管神经侵犯以及肿瘤亚型常表现为雌激素受体阴性,5年生存率更低。在我国,此年龄段女性乳腺病变筛查以超声和临床触诊为主,而钼靶检查一般作为40岁以上女性的常规筛查手段。因此对于40岁以下年轻女性乳腺癌的钼靶特点存在认识不足。
出处 《中国药物与临床》 CAS 2018年第9期1523-1525,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献4

二级参考文献39

  • 1Fondrinier E,Lorimier G,Guerin-Boblet V.Breast microcalcifications:Multivariate analysis of radiologic and clinical factors for carcinoma.World J Surg,2002,26:290
  • 2Lafontan BD,Daures JP,Salicru B,et al.Isolated clustered microcalcifications:Diagnostic value of mammography-series of 400 cases with surgical verification.Radiology,1994,190:479
  • 3Franceschi D,Crowe J,Zollinger R,et al.Biopsy of the breast for mammographically detected lesion.Surg Gynecol Obstet,1990,171:449
  • 4Hussain HK,Ng YY,Wells CA,et al.The significance of new densities and microcalcification in the second round of breast screening.Clin Radiol,1999,54:243
  • 5Speirs V,Kerin MJ.Prognostic significance of estrogen receptor beta in breast cancer.Br J Surg,2000,87:405
  • 6中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范(乳腺分册).北京:北京医科大学协和中国医科大学联合出版社,1991,22
  • 7Tanner M,Jarvinen P,Isola J.Amplification of HER-2/neu and topoisomerase Iialpha in primary and metastatic breast cancer.Cancer Res,2001,61:5345
  • 8Pienkowski T,Olszewski W,Kraszewska E,et al.Predictive value of HER-2 receptor,P53,bcl-2 and bax proteins,MIB-1 antibody,estrogene and progesterone receptor expression in breast cancer patients receiving adjuvant tamoxifen.Eur J Cancer,2002,38:116
  • 9Lohriseh C,Piccart M.HER-2/neu as a predictive factor in breast cancer.Clin Breast Cancer,2002,2:129
  • 10Ring AE,Ellis PA.Predictors of response to systemic therapy in breast cancer.Forum,2002,12:19

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部